Effect of exogenous progestogens on plasma concentrations of the oxytocin-associated neurophysin and 13,14-dihydro-15-keto-prostaglandin F in intact and ovariectomized ewes over the time of expected luteal regression.
Plasma concentrations of the prostaglandin F metabolite 13,14-dihydro-15-keto-prostaglandin F (PGFM), the oxytocin-associated neurophysin (OT-N) and progesterone were monitored by radioimmunoassay (RIA) in five ewes sampled from the jugular vein at hourly intervals between 0700-1900 h from Days 12-16 of the estrous cycle. These hormones were also determined in plasma samples collected at similar times from five intact and five ovariectomized ewes given twice daily injections of medroxyprogesterone acetate (MPA) over Days 10 to 20 after the last observed estrus. In both the control and intact MPA-treated ewes, coincident surges of OT-N and PGFM were observed in jugular plasma during the time of luteal regression. No significant differences were noted in the number and amplitude of OT-N and number of PGFM peaks between the control and intact MPA-treated animals, although in the latter the amplitude of the PGFM peaks was significantly reduced (P less than 0.01). No marked surges in the plasma concentrations of PGFM or OT-N were observed in the ovariectomized ewes given exogenous MPA. This latter finding is consistent with previous proposals, suggesting that the ovaries are a major source of oxytocin in the ewe. In addition, the observation that exogenous progestogens in the intact ewes did not influence the number and peak height of the OT-N surges, indicates that a fall in progesterone levels during the normal cycle is not obligatory for oxytocin release although it may facilitate the release of uterine PGF2 alpha.
D000818:Animals; D015237:Dinoprost / Q000031:analogs & derivatives; D004971:Estrus; D005260:Female; D003341:Luteolysis / Q000187:drug effects*; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000494:pharmacology; D017258:Medroxyprogesterone Acetate; D009481:Neurophysins / Q000097:blood*; D010053:Ovary / Q000502:physiology*; D011247:Pregnancy; D011374:Progesterone / Q000502:physiology; D011460:Prostaglandins F / Q000097:blood* / Q000378:metabolism; D012756:Sheep / Q000502:physiology*; D014599:Uterus / Q000378:metabolism
D009481:Neurophysins; D011460:Prostaglandins F; C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D011374:Progesterone; D015237:Dinoprost; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone